Peek, J., Lilic, M., Montiel, D., Milshteyn, A., Woodworth, I., Biggins, J. B., . . . Brady, S. F. (2018). Rifamycin congeners kanglemycins are active against rifampicin-resistant bacteria via a distinct mechanism. Nature Portfolio.
Chicago Style (17th ed.) CitationPeek, James, et al. Rifamycin Congeners Kanglemycins Are Active Against Rifampicin-resistant Bacteria via a Distinct Mechanism. Nature Portfolio, 2018.
MLA (8th ed.) CitationPeek, James, et al. Rifamycin Congeners Kanglemycins Are Active Against Rifampicin-resistant Bacteria via a Distinct Mechanism. Nature Portfolio, 2018.
Warning: These citations may not always be 100% accurate.